As AI evolves to deliver more powerful experiences by learning from our data, it is important to implement safeguards that ensure we are protecting personal privacy. By building AI with strict requirements around the protection of personal privacy, we can develop new technologies in a safe, ethical, and responsible way for the benefit of society.

‍DNAstack is honoured to accept the 2024 Health Privacy Leadership Award from the Canadian PICCASO Awards. The PICCASO Awards celebrate teams who have demonstrated cutting edge leadership and innovation in health data and privacy. The recognition of DNAstack in the category of Health Privacy underscores our commitment to developing innovative, AI-powered solutions that are capable of accelerating transformational outcomes across our health system while protecting personal privacy.

"Protecting the privacy of our most sensitive and personal health data is foundational to building trust across the ecosystem, including data custodians, consumers, and donors,” said Dr. Marc Fiume, CEO of DNAstack. “At DNAstack, our mission is to deliver AI-powered technologies that create a step change in health care while making it safer to do health research at national and planet scale. This award is a testament to our team's unwavering commitment to prioritize privacy as a foundational principle of the AI-enabled future of healthcare.”

DNAstack’s flagship software suite, Omics AI, makes it possible to connect and derive AI-powered insights across distributed networks of health data, without moving them. This eliminates the need to transfer sensitive information across institutional and geographic borders. Instead of following the standard model of “data sharing” where data contributors send data to researchers, Omics AI follows a new paradigm of “data federation” where researchers send questions to contributors. Each contributor in the federated network can approve researchers to ask specific questions in a privacy-preserving way while keeping sensitive data private. This approach is faster, more secure, scalable, and compliant, while also empowering data contributors to retain sovereignty and control.

‍

Omics AI is being used to power multiple collaborative research networks in neuroscience, oncology, infectious, and rare disease. For more information on how hospitals, governments, patient advocacy groups, pharmaceutical companies, and research consortia are leveraging DNAstack’s platform to accelerate discoveries while protecting personal privacy, visit https://omics.ai/studies/.